Stock held by Vijay Kedia and Mukul Agarwal jumps 7% after announcing its Q4 results
Shares of pharma ingredient maker jumped nearly 7% after the company reported its best-ever quarterly performance in Q4FY26. Ace investors Vijay Kedia, who holds a 1.01% stake, and Mukul Agarwal, who holds a 3.12% stake, are among the well-known names backing this stock.
Shares of pharma ingredient maker jumped nearly 7% after the company reported its best-ever quarterly performance in Q4FY26. Ace investors Vijay Kedia, who holds a 1.01% stake, and Mukul Agarwal, who holds a 3.12% stake, are among the well-known names backing this stock.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
